Roger A. Jeffs's most recent trade in Liquidia Corp was a trade of 32,744 Common Stock done at an average price of $71.5 . Disclosure was reported to the exchange on July 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 71.52 per share. | 10 Jul 2026 | 32,744 | 1,130,426 (4%) | 0% | 71.5 | 2,341,851 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2026 | 14,333 | 1,165,675 (4%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2026 | 14,333 | 143,329 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2026 | 13,834 | 1,151,342 (4%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Jul 2026 | 13,834 | 83,001 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 71.39 per share. | 10 Jul 2026 | 2,505 | 1,163,170 (4%) | 0% | 71.4 | 178,832 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 249.12 per share. | 10 Jun 2026 | 286 | 58,367 (0%) | 0% | 249.1 | 71,248 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 246.18 per share. | 10 Jun 2026 | 286 | 58,653 (0%) | 0% | 246.2 | 70,407 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2026 | 1,429 | 0 | - | - | Restricted Stock Units | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2026 | 1,429 | 58,939 (0%) | 0% | - | Common Stock | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2026 | 1,721 | 1,721 | - | - | Restricted Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 62.18 per share. | 27 May 2026 | 6,428 | 1,041,667 (3%) | 0% | 62.2 | 399,712 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 60.38 per share. | 21 May 2026 | 25,000 | 1,048,095 (3%) | 0% | 60.4 | 1,509,460 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.52 per share. | 21 May 2026 | 25,000 | 1,073,095 (3%) | 0% | 61.5 | 1,538,055 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.13 per share. | 21 May 2026 | 25,000 | 1,098,095 (3%) | 0% | 61.1 | 1,528,160 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.77 per share. | 18 May 2026 | 25,000 | 1,173,095 (4%) | 0% | 56.8 | 1,419,320 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.65 per share. | 18 May 2026 | 25,000 | 1,148,095 (4%) | 0% | 58.6 | 1,466,143 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 61.30 per share. | 18 May 2026 | 25,000 | 1,123,095 (3%) | 0% | 61.3 | 1,532,548 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 58.62 per share. | 13 May 2026 | 25,000 | 1,223,095 (4%) | 0% | 58.6 | 1,465,565 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 56.29 per share. | 13 May 2026 | 25,000 | 1,248,095 (4%) | 0% | 56.3 | 1,407,128 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 57.04 per share. | 13 May 2026 | 25,000 | 1,198,095 (4%) | 0% | 57.0 | 1,426,073 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 54.04 per share. | 08 May 2026 | 25,000 | 1,273,095 (4%) | 0% | 54.0 | 1,350,990 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 41.50 per share. | 08 May 2026 | 25,000 | 1,298,095 (4%) | 0% | 41.5 | 1,037,403 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 42.14 per share. | 08 May 2026 | 25,000 | 1,323,095 (4%) | 0% | 42.1 | 1,053,565 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.10 per share. | 05 May 2026 | 25,000 | 1,398,095 (4%) | 0% | 40.1 | 1,002,593 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 42.09 per share. | 05 May 2026 | 25,000 | 1,348,095 (4%) | 0% | 42.1 | 1,052,135 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.78 per share. | 05 May 2026 | 25,000 | 1,373,095 (4%) | 0% | 40.8 | 1,019,573 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.60 per share. | 17 Apr 2026 | 18,839 | 1,423,095 (5%) | 0% | 40.6 | 764,956 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.31 per share. | 14 Apr 2026 | 25,000 | 1,441,934 (5%) | 0% | 40.3 | 1,007,800 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.14 per share. | 14 Apr 2026 | 25,000 | 1,466,934 (5%) | 0% | 40.1 | 1,003,523 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 14 Apr 2026 | 3,300 | 1,491,934 (5%) | 0% | 40 | 132,000 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 38.37 per share. | 10 Apr 2026 | 32,744 | 1,137,599 (4%) | 0% | 38.4 | 1,256,387 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.12 per share. | 10 Apr 2026 | 21,433 | 1,495,234 (5%) | 0% | 40.1 | 859,877 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2026 | 14,333 | 1,170,343 (4%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2026 | 14,333 | 157,662 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2026 | 13,834 | 1,156,010 (4%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Apr 2026 | 13,834 | 96,835 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 40.12 per share. | 09 Apr 2026 | 25,000 | 1,516,667 (5%) | 0% | 40.1 | 1,002,888 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 173,016 | 173,016 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 115,344 | 1,152,872 (4%) | 0% | 0 | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 37.43 per share. | 09 Jan 2026 | 66,610 | 1,037,528 (3%) | 0% | 37.4 | 2,493,212 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 57,332 | 1,104,138 (3%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 57,332 | 171,995 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 13,833 | 1,046,806 (3%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Jan 2026 | 13,833 | 110,669 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 23.41 per share. | 10 Oct 2025 | 20,261 | 1,032,973 (3%) | 0% | 23.4 | 474,310 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2025 | 13,834 | 124,502 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Oct 2025 | 13,834 | 1,053,234 (3%) | 0% | - | Common Stock | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 123.68 per share. | 02 Sep 2025 | 13,464 | 57,510 (0%) | 0% | 123.7 | 1,665,228 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 121.60 per share. | 27 Aug 2025 | 20,000 | 90,974 (0%) | 0% | 121.6 | 2,432,000 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 122.30 per share. | 27 Aug 2025 | 20,000 | 110,974 (0%) | 0% | 122.3 | 2,446,000 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 121.27 per share. | 27 Aug 2025 | 20,000 | 70,974 (0%) | 0% | 121.3 | 2,425,400 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 120.03 per share. | 22 Aug 2025 | 20,000 | 130,974 (0%) | 0% | 120.0 | 2,400,600 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Sale of securities on an exchange or to another person at price $ 120.08 per share. | 22 Aug 2025 | 16,694 | 150,974 (0%) | 0% | 120.1 | 2,004,616 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.28 per share. | 11 Jul 2025 | 20,252 | 1,038,560 (3%) | 0% | 14.3 | 289,199 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.28 per share. | 11 Jul 2025 | 20,252 | 1,038,560 (3%) | 0% | 14.3 | 289,199 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 13,833 | 138,336 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 13,833 | 1,058,812 (3%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 13,833 | 138,336 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jul 2025 | 13,833 | 1,058,812 (3%) | 0% | - | Common Stock | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 3,166 | 3,166 | - | - | Stock Option (Right to Buy) | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2025 | 1,429 | 1,429 | - | - | Restricted Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 69,169 | 152,169 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2025 | 69,169 | 1,075,589 (3%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.97 per share. | 03 Jun 2025 | 30,610 | 1,044,979 (3%) | 0% | 17.0 | 519,452 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.57 per share. | 14 Apr 2025 | 14,130 | 1,006,420 (3%) | 0% | 13.6 | 191,744 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 1,408 | 1,408 | - | - | Stock Option (Right to Buy) | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 229,327 | 229,327 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2025 | 229,327 | 1,041,520 (3%) | 0% | 0 | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.78 per share. | 11 Jan 2025 | 22,343 | 1,019,177 (3%) | 0% | 11.8 | 263,201 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.11 per share. | 14 Oct 2024 | 8,053 | 812,193 (2%) | 0% | 11.1 | 89,450 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 12.53 per share. | 12 Jul 2024 | 8,053 | 818,932 (2%) | 0% | 12.5 | 100,904 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 07 Jun 2024 | 5,799 | 5,799 | - | - | Stock Option (Right to Buy) | ||
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 14.58 per share. | 12 Apr 2024 | 8,360 | 826,985 (2%) | 0% | 14.6 | 121,889 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 15.82 per share. | 18 Mar 2024 | 28,583 | 835,345 (2%) | 0% | 15.8 | 452,183 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 14 Mar 2024 | 16,976 | 0 | - | - | Stock Option (Right to Buy) | ||
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 14 Mar 2024 | 16,976 | 120,756 (0%) | 0% | 69.7 | 1,183,261 | Common Stock | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 14 Mar 2024 | 16,976 | 137,732 (0%) | 0% | 25.5 | 433,397 | Common Stock | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 14 Mar 2024 | 13,000 | 120,756 (0%) | 0% | 69.7 | 906,126 | Common Stock | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 14 Mar 2024 | 13,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 14 Mar 2024 | 13,000 | 133,756 (0%) | 0% | 22.0 | 286,390 | Common Stock | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 14 Mar 2024 | 2,347 | 0 | - | - | Stock Option (Right to Buy) | ||
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 14 Mar 2024 | 2,347 | 120,756 (0%) | 0% | 71.6 | 168,062 | Common Stock | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 14 Mar 2024 | 2,347 | 123,103 (0%) | 0% | 29.9 | 70,199 | Common Stock | |
| Axsome Therapeutics Inc | Roger Jeffs A. | Director | 27 Feb 2024 | 1,425 | 1,425 | - | - | Stock Option (Right to Buy) | ||
| Liquidia Corp | A. Jeffs Roger | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 221,338 | 221,338 | - | - | Performance Stock Units | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2024 | 221,338 | 862,143 (3%) | 0% | 0 | Common Stock | |
| Liquidia Corp | A. Roger Jeffs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 7.16 per share. | 14 Dec 2023 | 139,665 | 640,805 (2%) | 0% | 7.2 | 1,000,001 | Common Stock |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 02 Jun 2023 | 5,681 | 5,681 | - | - | Stock Option (Right to Buy) | ||
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 02 Mar 2023 | 2,082 | 2,082 | - | - | Stock Option (Right to Buy) | ||
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 15,807 | 207,249 (0%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 15,807 | 0 | - | - | Restricted Stock Unit | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 5.57 per share. | 06 Sep 2022 | 43,820 | 159,827 (0%) | 0% | 5.6 | 243,990 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 4.90 per share. | 31 Aug 2022 | 993 | 116,007 (0%) | 0% | 4.9 | 4,870 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 931,475 | 931,475 | - | - | Non-Qualified Stock Option (right to buy) | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 03 Jun 2022 | 16,976 | 16,976 | - | - | Stock Option (Right to Buy) | ||
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 3.53 per share. | 24 May 2022 | 28,000 | 46,595 (0%) | 0% | 3.5 | 98,812 | Common Stock |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2022 | 47,423 | 15,807 | - | - | Restricted Stock Unit | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2022 | 47,423 | 207,250 (0%) | 0% | - | Common Stock | |
| Liquidia Corp | Roger A. Jeffs | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 154,167 | 1,541,667 (5%) | 0% | 0 | Common Stock | |
| Axsome Therapeutics Inc | Roger A. Jeffs | Director | 04 Mar 2022 | 2,347 | 2,347 | - | - | Stock Option (Right to Buy) |